dc.contributor.author
Winter, G. E.
dc.contributor.author
Mayor Ruiz, C.
dc.date.issued
2024-03-22T09:21:47Z
dc.date.issued
2024-05-17T05:10:15Z
dc.date.issued
2023-11-17
dc.date.issued
2024-03-21T16:12:57Z
dc.identifier
https://hdl.handle.net/2445/209015
dc.description.abstract
Controlled interactions between macromolecules are fundamental regulatory layers. Hijacking these circuits via proximity-inducing small molecules offers many therapeutic opportunities. The organizers, Georg Winter and Cristina Mayor-Ruiz, report on the latest trends in this emerging field discussed at the 39th IRB-BioMed Conference in Barcelona.
dc.format
application/pdf
dc.publisher
Springer Science and Business Media LLC
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/s41589-023-01492-2
dc.relation
Nature Chemical Biology, 2024, vol. 20, num. 1, p. 13-14
dc.relation
https://doi.org/10.1038/s41589-023-01492-2
dc.rights
(c) Springer, 2024
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
dc.subject
Macromolècules
dc.subject
Macromolecules
dc.title
Targeted protein degradation: Proximity-inducing pharmacology
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
